Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in vascular dementia.

J L Cummings1

  • 1Neurobehavior Unit, West Los Angeles VAMC 90073.

The Hillside Journal of Clinical Psychiatry
|January 1, 1988
PubMed
Summary

Depression frequently complicates vascular dementia, affecting 25-80% of patients. This depression, linked to frontal lobe lesions and other factors, responds well to antidepressant treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

International psychogeriatrics·2025
Same author

Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults.

The journal of prevention of Alzheimer's disease·2022
Same author

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).

The journal of prevention of Alzheimer's disease·2020
Same author

TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.

The journal of prevention of Alzheimer's disease·2020
Same author

The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.

The journal of prevention of Alzheimer's disease·2020
Same author

Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.

International journal of clinical practice·2015

Area of Science:

  • Neurology
  • Psychiatry
  • Gerontology

Background:

  • Vascular dementia (VCD) stems from brain ischemic injury.
  • Depression is a common complication in VCD, affecting 25-80% of patients.
  • Depression symptoms in VCD mirror those of late-onset major depressive episodes.

Purpose of the Study:

  • To investigate the prevalence and characteristics of depression in vascular dementia.
  • To identify factors contributing to depression in VCD.
  • To assess the treatment response of depression in VCD.

Main Methods:

  • The study reviewed existing literature on VCD and depression.
  • Analysis focused on symptom profiles, lesion sites, and contributing factors.
  • Treatment outcomes with antidepressant agents were examined.

Main Results:

  • Depression frequency varies by VCD subtype, most common with frontal lobe lesions.
  • Depression is unrelated to intellectual decline or delusions.
  • Contributing factors include lesion location, comorbidities, and psychological responses.

Conclusions:

  • Depression is a significant and treatable complication of vascular dementia.
  • Frontal lobe lesions are associated with higher depression rates.
  • Antidepressant therapy is effective for VCD-related depression.

Related Experiment Videos